VCAM1 and myeloid sarcoma: For example, in multiple sclerosis (MS), miR-126 suppresses immune cell infiltration into the CNS by targeting vascular cell adhesion molecule 1 (VCAM-1), thereby reducing neuroinflammation-mediated fatigue.